Table 4. Univariate and multivariate analysis of prognostic factors for overall survival in gastric cancer patients.
Univariate analysis | Multivariate analysis | |||||||
---|---|---|---|---|---|---|---|---|
HR | P >|z| | 95% CI | HR | P >|z| | 95% CI | |||
IDH1-R132H expression | ||||||||
High vs Low | 0.634 | 0.001* | 0.485 | 0.829 | 0.587 | 0.019* | 0.377 | 0.915 |
Age (years) | ||||||||
≤60 vs >60 | 1.134 | 0.352 | 0.870 | 1.480 | ||||
Gender | ||||||||
Male vs Female | 0.892 | 0.425 | 0.674 | 1.181 | ||||
Histological type | ||||||||
Tubular vs Mixed (Tubular and mucinous) vs Mucinous vs Signetring cell carcinoma vs othersa | 1.019 | 0.779 | 0.892 | 1.165 | ||||
Differentiation | ||||||||
Well vs Middle vs Poor | 1.639 | <0.001* | 1.250 | 2.149 | 1.300 | 0.220 | 0.855 | 1.978 |
TNM stage | ||||||||
0+Ia vs Ib vs IIa vs IIb vs IIIa vs IIIb vs IIIc and IV | 1.529 | <0.001* | 1.410 | 1.658 | 1.533 | <0.001* | 1.341 | 1.753 |
T | ||||||||
Tis+T1 vs T2 vs T3 vs T4 | 1.765 | <0.001* | 1.462 | 2.130 | ||||
N | ||||||||
N0 vs N2 vs N3 | 1.642 | <0.001* | 1.472 | 1.831 | ||||
M | ||||||||
M0 vs M1 | 3.188 | <0.001* | 2.066 | 4.919 | ||||
Preoperative CEA,(ng/ml) | ||||||||
≤ 5 vs ≥ 5 | 2.279 | <0.001* | 1.580 | 3.286 | 2.432 | <0.001* | 1.534 | 3.855 |
Preoperative CA199, (U/ml) | ||||||||
≤ 37 vs>37 | 2.422 | <0.001* | 1.573 | 3.730 | 1.503 | 0.142 | 0.873 | 2.589 |
P<0.05;
others: papillary adenocarcinoma, 3 cases; adeno-squamous carcinoma, 3 cases; squamous cell carcinoma, 2 cases; neuroendocrine carcinoma,1 case; carcinoid,1 case;
others: besides tubular.